Innovative genetic approaches to rare disease diagnosis

FHS
July 22, 2024
5:57 pm

The majority of rare diseases have a genetic cause. The underlying genetic alteration can be found more and more easily, for example by means of exome sequencing (ES), leading to a molecular genetic diagnosis.

World’s first CRISPR-based gene therapy approved for sickle cell anaemia – Pharmaceutical Technology

Share this article Casgevy has been approved for treating sickle cell disease and transfusion-dependent beta thalassemia patients aged 12 and older in the UK. Image

November 16, 2023

Could private equity be the future of private practice? A new lobbying group thinks so

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their

January 16, 2024

De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer

Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show noninferiority versus standard care, which “reset the bar” for future trials

October 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.